Financial Services Guide
  1. Home
  2. Financial Services Guide
Cyclopharm Limited (ASX: CYC) – Exponential...
By ACE Investors / 13 Jun 2024
Read More
Medadvisor Limited (ASX: MDR): Continued Grow...
By ACE Investors / 28 May 2024
Read More
Aroa Biosurgery Limited (ASX: ARX) Well Estab...
By ACE Investors / 28 May 2024
Read More
Regis Healthcare Limited (ASX: REG): Pursue S...
By ACE Investors / 24 May 2024
Read More
Trajan Group Holdings Limited (ASX: TRJ): Ran...
By ACE Investors / 23 May 2024
Read More
Paradigm Biopharmaceuticals Limited (ASX: PAR...
By ACE Investors / 23 May 2024
Read More
Botanix Pharmaceuticals Limited (ASX: BOT): S...
By ACE Investors / 21 May 2024
Read More
Curvebeam AI Limited (ASX: CVB) – Potential...
By ACE Investors / 17 May 2024
Read More
Gilead Sciences, Inc. (NASDAQ: GILD) Leading ...
By ACE Investors / 16 May 2024
Read More
Chimeric Therapeutics Limited (ASX: CHM): Ach...
By ACE Investors / 14 May 2024
Read More
Percheron Therapeutics Limited (ASX: PER) –...
By ACE Investors / 10 May 2024
Read More
Anika Therapeutics, Inc. (NASDAQ: ANIK): Stre...
By ACE Investors / 02 May 2024
Read More
ABN No: 70 637 702 188 | ACN NO: 637 702 188
Copyright © 2024 ACE Investors. All Right Reserved. Design by Ace Investors